A study by Bolisetty et al. confirmed that induction of HO-1 expression in hepatoma cells treated with the ferroptosis inducer erastin had an inhibitory effect on the formation of ferroptosis [25]. Here, HMOX1 is linked to hepatocellular carcinoma.